BlackRock’s Scribe Therapeutics SCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12.5M Buy
+679,786
New +$17.9M ﹤0.01% 3543

Other funds holding SCTX

BlackRock's SCTX Position: Q3 2026 in Review

BlackRock opened a new position in Scribe Therapeutics (SCTX) in Q3 2026: 679,786 shares worth $12.5M. The stake represents ﹤0.01% of the portfolio and ranks #3543 among its holdings.

62 funds tracked by Wall St. Rank hold SCTX as of Q3 2026.

  • BlackRock held 679,786 shares of Scribe Therapeutics worth $12.5M as of Q3 2026.
  • Scribe Therapeutics was a new BlackRock position in Q3 2026.
  • Scribe Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q3 2026, its #3543 holding.
  • 62 funds tracked by Wall St. Rank held Scribe Therapeutics as of Q3 2026.

Based on BlackRock's 13F filing for Q3 2026, filed 13 Nov 2026.